Glycoprotein IIb/IIIa inhibitors use in the setting of primary percutaneous coronary intervention for ST elevation myocardial infarction in patients pre-treated with newer P2Y12 inhibitors.

Still, in the sub‐analysis of ATLANTIC trial, stent thrombosis was numerically more frequent in the group without GPI but the difference did not reach statistical significance (1.1% vs. 0.2%, p = .13). 14 Conversely our study did not show any benefit nor trend in favor of GPI to prevent stent thrombosis.

also in 111,027 other papers